Runcharoen, Chakkaphan
Fukunaga, Koya
Sensorn, Insee
Iemwimangsa, Nareenart
Klumsathian, Sommon
Tong, Hang
Vo, Nam Sy
Le, Ly
Hlaing, Tin Maung
Thant, Myo
Zain, Shamsul Mohd
Mohamed, Zahurin
Pung, Yuh-Fen
Capule, Francis
Nevado, Jose Jr.
Silao, Catherine Lynn
Al-Mahayri, Zeina N. http://orcid.org/0000-0002-4673-6692
Ali, Bassam R.
Yuliwulandari, Rika http://orcid.org/0000-0003-1682-6280
Prayuni, Kinasih
Zahroh, Hilyatuz
Noor, Dzul Azri Mohamed
Xangsayarath, Phonepadith
Xayavong, Dalouny
Kounnavong, Sengchanh
Sayasone, Somphou
Kordou, Zoe
Liopetas, Ioannis
Tsikrika, Athina
Tsermpini, Evangelia-Eirini http://orcid.org/0000-0002-8592-7790
Koromina, Maria
Mitropoulou, Christina
Patrinos, George P.
Kesornsit, Aumpika
Charoenyingwattana, Angkana
Wattanapokayakit, Sukanya
Mahasirimongkol, Surakameth
Mushiroda, Taisei
Chantratita, Wasun
Funding for this research was provided by:
Thailand Research Fund (IRN60W0003, IRN60W0003, IRN60W0003)
Thailand Center of Excellence for Life Sciences
Vietnam National University at Ho Chi Minh City
Vingroup Innovation Fund
Vietnam National University at Ho Chi Minh City
Ministry of Higher Education (MoHE)
UAEU and Ministry of Education for funding
European commission
European commission
Article History
Received: 24 July 2020
Revised: 24 November 2020
Accepted: 28 November 2020
First Online: 4 February 2021
Conflict of interest
: The authors declare that they have no conflicts of interest. GPP is a Full Member and a National Representative of the European Medicines Agency, CHMP-Pharmacogenomics Working Party, Amsterdam, the Netherlands.